AU732997B2 - NMDA (N-methyl-D-aspartate) antagonists - Google Patents

NMDA (N-methyl-D-aspartate) antagonists Download PDF

Info

Publication number
AU732997B2
AU732997B2 AU40718/97A AU4071897A AU732997B2 AU 732997 B2 AU732997 B2 AU 732997B2 AU 40718/97 A AU40718/97 A AU 40718/97A AU 4071897 A AU4071897 A AU 4071897A AU 732997 B2 AU732997 B2 AU 732997B2
Authority
AU
Australia
Prior art keywords
compound
propenoic acid
acid
dichloroindol
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU40718/97A
Other languages
English (en)
Other versions
AU4071897A (en
Inventor
Bruce M. Baron
Raymond S. Gross
Boyd L. Harrison
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Publication of AU4071897A publication Critical patent/AU4071897A/en
Assigned to AVENTIS PHARMACEUTICALS INC. reassignment AVENTIS PHARMACEUTICALS INC. Amend patent request/document other than specification (104) Assignors: HOECHST MARION ROUSSEL, INC.
Application granted granted Critical
Publication of AU732997B2 publication Critical patent/AU732997B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU40718/97A 1996-09-30 1997-08-18 NMDA (N-methyl-D-aspartate) antagonists Ceased AU732997B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72317596A 1996-09-30 1996-09-30
US08/723175 1996-09-30
PCT/US1997/014486 WO1998014427A1 (en) 1996-09-30 1997-08-18 Nmda (n-methyl-d-aspartate) antagonists

Publications (2)

Publication Number Publication Date
AU4071897A AU4071897A (en) 1998-04-24
AU732997B2 true AU732997B2 (en) 2001-05-03

Family

ID=24905175

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40718/97A Ceased AU732997B2 (en) 1996-09-30 1997-08-18 NMDA (N-methyl-D-aspartate) antagonists

Country Status (18)

Country Link
EP (1) EP0929521B1 (ko)
JP (1) JP2001501221A (ko)
KR (1) KR20000048715A (ko)
CN (1) CN1139572C (ko)
AR (1) AR009374A1 (ko)
AT (1) ATE309215T1 (ko)
AU (1) AU732997B2 (ko)
BR (1) BR9712144A (ko)
CA (1) CA2266556C (ko)
DE (1) DE69734594T2 (ko)
DK (1) DK0929521T3 (ko)
HU (1) HUP0000882A3 (ko)
IL (1) IL129187A0 (ko)
NO (1) NO314080B1 (ko)
NZ (1) NZ334343A (ko)
TW (1) TW492958B (ko)
WO (1) WO1998014427A1 (ko)
ZA (1) ZA978602B (ko)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010053849A1 (en) * 1999-06-16 2001-12-20 Mary Jeanne Kreek Plural biological sample arrays, and preparation and uses thereof
IL152473A0 (en) 2000-04-28 2003-05-29 Sloan Kettering Inst Cancer Topical anesthetic/opioid formulations and uses thereof
HU227197B1 (en) 2000-10-24 2010-10-28 Richter Gedeon Nyrt Nmda receptor antagonist carboxylic acid amide derivatives and pharmaceutical compositions containing them
US7820688B2 (en) 2001-04-27 2010-10-26 Memorial Sloan-Kettering Cancer Center Topical anesthetic/opioid formulations and uses thereof
US20030162825A1 (en) * 2001-11-09 2003-08-28 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
DE10306202A1 (de) 2003-02-13 2004-08-26 Grünenthal GmbH Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
CN101896457A (zh) * 2007-10-22 2010-11-24 幽兰研究实验室有限公司 组蛋白脱乙酰基酶抑制剂
IN2012DN06631A (ko) 2010-02-16 2015-10-23 Pfizer
US11613547B2 (en) 2019-07-08 2023-03-28 University Of Health Sciences & Pharmacy In St. Louis G-protein biased opioid receptor agonist/analgesics with reduced arrestin recruitment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2088011T3 (es) * 1990-07-16 1996-08-01 Merrell Pharma Inc Antagonistas de aminoacidos excitadores.
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
US5519048A (en) * 1993-05-27 1996-05-21 Merrell Pharmaceuticals Inc. 3-(indol-3-yl)-propenoic acid derivatives and pharmaceutical compositions thereof
HU216633B (hu) * 1993-05-27 1999-07-28 Merrel Pharmaceuticals Inc. NMDA-antagonista hatású 3-(indol-3-il)-propénsav-származékok, ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
GB9319243D0 (en) * 1993-09-17 1993-11-03 Glaxo Spa Heterocyclic compounds

Also Published As

Publication number Publication date
DE69734594D1 (en) 2005-12-15
ZA978602B (en) 1998-03-30
BR9712144A (pt) 1999-08-31
DE69734594T2 (de) 2006-07-06
CA2266556C (en) 2007-11-06
HUP0000882A3 (en) 2001-04-28
CN1232452A (zh) 1999-10-20
NO991533D0 (no) 1999-03-29
DK0929521T3 (da) 2006-03-27
IL129187A0 (en) 2000-02-17
NO991533L (no) 1999-05-28
CA2266556A1 (en) 1998-04-09
NO314080B1 (no) 2003-01-27
HUP0000882A2 (hu) 2000-09-28
AR009374A1 (es) 2000-04-12
EP0929521A1 (en) 1999-07-21
ATE309215T1 (de) 2005-11-15
JP2001501221A (ja) 2001-01-30
TW492958B (en) 2002-07-01
AU4071897A (en) 1998-04-24
NZ334343A (en) 2001-01-26
CN1139572C (zh) 2004-02-25
KR20000048715A (ko) 2000-07-25
EP0929521B1 (en) 2005-11-09
WO1998014427A1 (en) 1998-04-09

Similar Documents

Publication Publication Date Title
US6358992B1 (en) Method of inhibiting neoplastic cells with indole derivatives
ES2281975T3 (es) Derivados 3-sustituidos de 4-arilquinolin-2-ona como moduladores de los canales de potasio.
AP480A (en) 3-Substituted indole 2-carboxylic acid derivatives.
JP3168565B2 (ja) ３−アミドインドリル誘導体類
JPH07215947A (ja) １−ベンゼンスルホニル−１，３−ジヒドロ−２ｈ−ベンズイミダゾール−２−オン誘導体
MX2008003202A (es) Derivados de carbazol.
AU732997B2 (en) NMDA (N-methyl-D-aspartate) antagonists
JPH09512528A (ja) バソプレッシン拮抗物質としてのベンズアミド誘導体
EP0526478B1 (en) 3-indolyl thioacetate derivatives
JP3168566B2 (ja) Ｎｍｄａ拮抗剤
US5922752A (en) NMDA (n-methyl-d-aspartate) antagonists
US5981553A (en) Heterocycle substituted propenoic acid derivatives as NMDA antagonist
JP3334805B2 (ja) ３−（インドール−３−イル）−プロペン酸誘導体類及びその製剤組成物
FI103202B (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-sulfonamido-1,4-dihydroki noliiinijohdannaisten valmistamiseksi
MXPA97003146A (en) Derivatives of propenoic acid substituted conheterocicle as n antagonists
MXPA99002983A (en) Nmda (n-methyl-d-aspartate) antagonists
NZ266372A (en) 3-indol-3-yl-2-phenylpropenoic acid derivatives; pharmaceutical compositions
JP2003246732A (ja) １，２−エタンジオール誘導体またはその塩を含有する神経断裂治療剤

Legal Events

Date Code Title Description
TC Change of applicant's name (sec. 104)

Owner name: AVENTIS PHARMACEUTICALS INC.

Free format text: FORMER NAME: HOECHST MARION ROUSSEL, INC.

FGA Letters patent sealed or granted (standard patent)